1-(3-(4-Fluorophenoxy)propyl)piperazine dihydrochloride

Catalog No. :
ACWUDT213
CAS No. :
537037-78-8
Molecular Formula :
C13H21Cl2FN2O
Molecular Weight :
311.23

IUPAC Name:1-(3-(4-fluorophenoxy)propyl)piperazine dihydrochloride

1-(3-(4-Fluorophenoxy)propyl)piperazine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00Login to see priceInquiryInquiry
1g95%$214.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-(4-Fluorophenoxy)propyl)piperazine dihydrochloride
IUPAC Name1-(3-(4-fluorophenoxy)propyl)piperazine dihydrochloride
MDL No.MFCD03428570
Molecular FormulaC13H21Cl2FN2O
Molecular Weight311.23
SMILESFC1=CC=C(OCCCN2CCNCC2)C=C1.[H]Cl.[H]Cl
InChI KeyVMRGSSVEEBFOGX-UHFFFAOYSA-N
Synonym1-[3-(4-Fluorophenoxy)prop-1-yl]piperazine dihydrochloride 97%;1-Fluoro-4-[3-(piperazin-1-yl)propoxy]benzene dihydrochloride;1-[3-(4-Fluorophenoxy)prop-1-yl]piperazinedihydrochloride97%;1-(3-(4-Fluorophenoxy)propyl)piperazine*2HCl;1-(3-(4-Fluorophenoxy)propyl)piperazine*2HCI;1-[3-(4-Fluorophenoxy)prop-1-yl]piperazine dihydrochloride
CAS No.537037-78-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWUDT213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWUDT213 route product structure diagram
    ACWUDT213537037-78-8
Inquiry

2. ACWUDT213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWUDT213 route product structure diagram
    ACWUDT213537037-78-8
Inquiry

Comments (0)